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In Xenopus, the dorso-ventral (D/V) axis is thought to be specified by the bone morphogenetic proteins (Bmp) activity arising through
interaction with antagonists such as Noggin, Chordin and Follistatin. We report here, through inactivation of noggin1 (nog1) that this gene is not
essential by itself to establish the D/V patterning. However, at blastula stage, inactivation of nog1 strongly amplifies chordin (chd) phenotype,
revealing redundant functions of these two genes on D/V axis formation. Substantial dorsal tissues remaining in the double nog1-chd morphant
suggested that other anti-Bmp factors may pattern the D/Vaxis. We isolated two potential candidates, the follistatin-like (fstl) genes. We found that
fstl2 is an early gastrula expressed gene. Its inactivation, similar to nog1, strongly enhances the chd phenotype. Moreover, the penetrance of the
ventralization phenotype is much higher when we inactivated simultaneously chd, nog1 and fstl2.
Altogether, our data reveal that, while Chordin is the main player of the D/V axis, sufficient to maintain proper activity of Bmp gradient, the
structures remaining in the chd mutant (namely dorsal and dorso-lateral territories, in both mesodermal and ectodermal layers) result from the anti-
Bmp activity carried by Nog1 and Fstl2 at blastula and gastrula stages.
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The dorso-ventral axis of the Xenopus embryo is thought to
be specified by a gradient of bone morphogenetic proteins
activity that in part arises through the interaction with
antagonists emanating from the dorsal organizer, Noggin,
Chordin and Follistatin. These three factors bind to Bmps
preventing them to activate their receptors, thereby blocking
Bmp ventralizing properties (Piccolo et al., 1996; Zimmerman et
al., 1996). Modulating this interaction is a metalloprotease
Tolloid, which cleaves Chordin, allowing refining the limits of
its activity in vivo (Marques et al., 1997; Piccolo et al., 1997;
Connors et al., 1999). The key role for Bmp signaling in dorso-
ventral (D/V) patterning was further supported by genetic
analyses performed in the zebrafish and in the mouse models. To
exemplify, in the zebrafish, dorsalized swirl mutants are altered⁎ Corresponding author. Fax: +33 3 88 65 32 01.
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doi:10.1016/j.ydbio.2006.07.002in the bmp2b gene (Kishimoto et al., 1997; Nguyen et al., 1998)
whereas the dorsalized snailhouse mutation is defective in the
bmp7 gene, revealing equivalent genetic roles for these two
Bmp ligands (Schmid et al., 2000; Dick et al., 2000). Further
analysis revealed that Bmp2b and Bmp7 synergize in a cell-
autonomous mechanism, suggesting that Bmp2b/Bmp7 hetero-
dimers act in vivo to specify ventral cell fates (Schmid et al.,
2000).
Two additional mutations were identified within the course
of zebrafish mutagenesis screens to produce ventralized
phenotypes. The first mutation is chordino (din) that affects
the chordin locus (Miller-Bertoglio et al., 1997; Schulte-Merker
et al., 1997), and the second one is ogon (Hammerschmidt et al.,
1996; Miller-Bertoglio et al., 1999), which codes for Sizzled, a
member of the frizzled-related protein family (Martyn and
Schulte-Merker, 2003; Yabe et al., 2003). The Xenopus
homologue of Sizzled was recently shown to affect the D/V
patterning through binding and inhibition of Tolloid. A similar
activity for Sizzled in the zebrafish was recently described
(Muraoka et al., 2006 and our unpublished observations).
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inactivation of Chordin (Lee et al., 2006; Muraoka et al.,
2006).
While the noggin and follistatin genes were also identified in
zebrafish, their implication in the establishment of the D/V
patterning was far less clear because their possible implication
on this process relied only on overexpression analyses (Bauer et
al., 1998; Fürthauer et al., 1999). We isolated three noggin genes
(Fürthauer et al., 1999), and two follistatin genes (Bauer et al.,
1998 and this report) were found in the zebrafish genome. Gene
expression analysis revealed that noggin2, noggin3, follistatin1
and follistatin2 are expressed too late during embryonic deve-
lopment to play a role in the establishment of the D/V patterning.
On the other hand, noggin1 is expressed at the dorsal blastula
margin, making this factor a potential good candidate for its
involvement in this process. In addition, we identified a novel
member of the follistatin gene superfamily called follistatin-
like2 (fstl2), which is expressed in dorsal tissues at early gastrula
stages, suggesting an implication of this factor in D/V patterning
as well.
In the present study, we investigate the implication of nog-
gin1 and follistatin-like2 in the establishment of the D/V
patterning by loss of function experiments using the morpholino
knock-down technology. Conversely to overexpression results,
inactivation of noggin1 has no effect on zebrafish D/V
patterning. However, inactivation of noggin1 together with
chordin strongly enhances the ventralization phenotype ob-
served after single loss of chordin. Similar results are obtainedFig. 1. Comparative analysis of ventralization phenotypes. Homozygous mutant em
morphants in ogon mutant background (C) display ventralization phenotypes similar
Injection of 5 pg bmp2b RNA (E) results in stronger ventralization with complete
patterning and embryos appear radialized. At the onset of gastrulation, ogo transcripts
broad dorsal domain, which includes the nog1 expression territory (I). Embryos arewith follistatin-like2. Moreover, triple inactivation of noggin1,
chordin and follistatin-like2 leads to extreme ventralization.
Altogether, our results clearly show that Chordin, Noggin1 and
Follistatin-like2 function redundantly to control the establish-
ment of the D/V axis of the zebrafish embryo.Materials and methods
Zebrafish mutations
The spontaneous mutation ogo m60 (ogo) and dino tm84 (din) were used
(Hammerschmidt et al., 1996; Miller-Bertoglio et al., 1999).
Whole-mount in situ hybridizations
Whole-mount in situ hybridizations were performed as described by Thisse
et al. (2004) using the following probes.
Probes for sox19 (clone CB799), starmaker (clone CB885), ved (clone
CB675), im:7144261, cyp26a (clone CB24), foxi1 (clone CB724), drl (clone
CB253), myf5 (clone CB641), fst1 (clone CB446) and hgg1 (clone CB15) were
prepared as described in Thisse et al. (2001) and Thisse et al. (2004).
The probes for flhwere prepared as described in Talbot et al. (1995), for nog1
as described in Fürthauer et al. (1999) and for chd as described in Schulte-Merker
et al. (1997). For ogon an RT-PCR fragment containing the full ORF of sizzled
was cloned into a TOPO vector and the antisense probe was synthesized after
PCR amplification of the insert with the PU and RP primers using the T7 RNA
polymerase.
For fst2 (sequence accession number: DQ317969), a 3′UTR fragment was
PCR-amplified and subcloned into the BamHI/XhoI sites of pBSKII (+). For
probe synthesis, the vector was linearized with BamHI and antisense RNA
synthesized using T7 RNA Polymerase.bryos for chordin (din/din, panel A), ogon (ogo/ogo, panel B) as well as chd
to those obtained after injection of low amount of bmp2b RNA (1 pg, panel D).
loss of head while injection of 20 pg RNA (F) completely abolishes the D/V
(G) are observed in the ventral part of the embryo while chd (H) is expressed in a
in lateral view, anterior to the left (A–F) or anterior to the top (G–I).
Fig. 3. Inactivation of noggin1 enhances the ventralization phenotype of chor-
din loss of function. (A) MO-chd-injected embryos at 30 hpf. (B–F) Injection of
MO-chd together with MO-nog1 leads to (B) class 1 (C1) embryos
corresponding to a weak enhancement of chd phenotype. In class 2 (C2)
embryos, the ventralization phenotype following (C) injection of MO-chd and
MO-nog1 or (D) injection of MO-nog1 in chordino (din/din) mutant is more
pronounced than in class 1, with loss of most of the head territory. (E, F) In class
3 (C3) embryos, the ventralization after double chd-nog1 MO injection is
stronger with an almost complete disappearance of anterior and dorsal
territories. Lateral views, anterior to the left.
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inserted in the PstI/XbaI sites of pBSKII (+). For probe synthesis, the template
was linearized with PstI and antisense RNA synthesized using T3 RNA
polymerase.
For fstl2 (sequence accession number: DQ317971), library screening led to
the isolation of a 3 kb full-length cDNA inserted into the EcoRI/XhoI sites of
pBSKII (+). For in situ hybridization, this vector was linearized with BamHI
and antisense RNA synthesized using T7 RNA polymerase to generate a 2 kb
3′UTR probe.
Injections
Morpholinos (Gene Tools) were resuspended in Danieau 1×, stored at
−20°C as a 4 mM stock solution and diluted before use to the appropriate




MOa-nog1: GCGGGAAATCCATCCTTTTGAAATC covering the ATG
of initiation of nog1 translation
MOb-nog1: GAGATTAAACGCGGGATTTATCCGT located in the 5′
UTR, upstream of the nog1 initiation codon
morpholinos follistatin1:
MOa-fst1: CTGACGCTTTAGCATCCTTAGCATG covering the fst1
translation initiation site
MOb-fst1: GACGAGCAGCGCAAAAGTAATCTTC located in the 5′
UTR, upstream of the fst1 initiation site
morpholinos follistatin-like 2:
MOa-fstl2: AAACACGGGTAAACACCGAAACATC covering the
ATG of initiation of fstl2 translation
MOb-fstl2: AAAAAACGCCGCCTGGGTGTCTGT located in the 5′
UTR, upstream of the fstl2 initiation codon
morpholino ogon:
MO-ogo: ACAGCAGCAGACTGAATAGAGACAT.
For overexpression experiments, cDNAs (fgf8, fst1 and fstl2) inserted into
pCS2+ were linearized withNotI and transcribed using the SP6 RNA polymerase.
For mRNA and morpholino injections, embryos were dechorionated using
Pronase E and injected with either RNA or morpholinos diluted in 0.2% Phenol
Red and 0.1 M KCl, using an Eppendorf 5426 microinjector.
Phenotypic analyses
For morphological analysis, embryos were sorted out into 3 different classes
according to their D/V axis defects and named C1 (ventralization similar toFig. 2. noggin1 morphants display normal D/V patterning. Compared to wild-
type at 30 hpf (A), MO-nog1-injected embryos (B) display normal D/Vaxis, but
a thinner yolk tube extension (arrowhead) and a protruding telencephalon. At
higher magnification, cerebellum (arrowhead in panel D) appears smaller
compared to wild-type (arrowhead in panel C). Lateral views, anterior to the left.ventralization of chd loss of function), C2 (strong ventralization, with complete
deletion of anterior head) and C3 (extreme ventralization—complete loss of head
structures), while for the analysis after whole-mount in situ hybridization,
embryos were sorted out into 2 different classes labeled CI (weak ventralization)
and CII (strong ventralization) at early developmental stages and into 3 classes
(CI to CIII from weak ventralization – CI – to extreme ventralization—CIII) at
30 hpf.
Results
Within the course of genetic screens (Hammerschmidt et al.,
1996; Solnica-Krezel et al., 1996), the din and ogo mutant
embryos were described to share a characteristic ventralized
phenotype, with reduction of the head, expansion of the ventral
hematopoietic territory and a partial loss of the posterior
notochord (Hammerschmidt et al., 1996, Fig. 1A, Miller-
Bertoglio et al., 1999, Fig. 1B). However, the phenotype of
chd loss of function is slightly stronger than loss of function of
sizzled (compared Figs. 1A to 1B). As described in Yabe et al.
(2003), concomitant inactivation of chd and ogo generate
ventralization phenotype similar to chd loss of function (Fig.
1C). However, these ventralization phenotypes observed after
single or double inactivation of chd and/or ogo are still less
severe than the ventralization phenotypes obtained upon over-
expression of bmp2b RNA (Figs. 1D–F). Injection of progres-
sive doses of bmp2b RNA (from 1 to 20 pg RNA) into 1-cell
Table 1






wt C1 C2 C3
MO-chd 100 174 1.2 98.8 0 0
[din/+×din/+] – 59 65.7 34.3 0 0
MO-chd/MOa-nog1 100/500 69 – 46.4 49.3 4.3
MO-chd/MOa-nog1 100/750 307 – 34.6 56.6 8.8
MO-chd/MOa-nog1 100/1000 77 – 40.2 41.8 18
MO-chd/MOb-nog1 100/750 66 – 43.9 50 6.1
MO-chd/MOb-nog1 100/1000 86 – 43.5 41.4 15.1
MOa-nog1 in [din/+×din/+] 750 85 74.7 8.4 16.9 0
MOa-nog1 in [din/+×din/+] 1000 59 83.0 0 17.0 0
Percentage of embryos (n: number of embryos analyzed) of the different
phenotypic classes defined in Fig. 3 in function of conditions used (concentration
of MO, mutant background).
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highest dose to complete ventralization and spindle-shaped
embryos (Schmid et al., 2000, Fig. 1F). This suggests that, inFig. 4. Analysis of double chordin–noggin1 morphants for the expression of tissue
molecular markers, sox19 labeling the central nervous system, starmaker labeling t
embryos while the others embryos are injected with MO-chd and MO-nog1 in con
ventralization phenotype, (C, G, K, O) strong ventralization—class II—CII, and (D,
(M–P). In dorsal view (E–L), anterior to the left.addition to Chd and Ogo, other Bmp antagonists may be
required to pattern the D/V axis.
Gain of function studies we performed in the past suggested
that the noggin1 gene (nog1) could be a potential candidate to
be involved in the early D/V patterning (Fürthauer et al., 1999).
In the zebrafish, we cloned three noggin genes and found that
their combined expressions recapitulate the different aspects of
the expression of the single noggin gene of other vertebrates.
All three noggin when overexpressed are able to dorsalize the
embryo. However, only nog1 is expressed in the fish organizer
at blastula and early gastrula stages, in a location and at a time
compatible with its potential implication in D/V patterning.
By comparing expression territories of nog1 with those of
ogo and chd, we found that ogo transcripts are located on the
ventral side, in a territory similar to bmp expression domain
(Fig. 1G), compatible with its potential function as a negative
feedback regulator of Bmp (Yabe et al., 2003). Chd territory of
expression is located in a broad dorso-marginal domain that
includes the dorsal organizer (Schulte-Merker et al., 1997, Fig.
1H). Nog1 expression is included within the chd expression-specific molecular markers at 30 hpf. Expression at 30 hpf of three different
he otic vesicle and im:7144261 labeling the notochord. (A, E, I, M) Wild-type
ditions described in Table 2. (B, F, J, N) Weak aggravation (class I, CI) of the
H, L, P) extreme ventralization (class 3, CIII). Embryos in lateral view (A–D),
Table 2






Marker n Phenotypes (%)
wt like CI CII CIII
MOa-nog1 500 sox19 17 100 0 0 0
MOa-nog1 1000 sox19 50 100 0 0 0
MO-chd 100 sox19 79 36.7 63.3 0 0
MO-chd/
MOa-nog1
100/500 sox19 23 34.8 4.4 39.1 21.7
MO-chd/
MOa-nog1
100/1000 sox19 191 13.1 12.0 57.6 17.3
MOa-nog1 500 starmaker 27 100 0 0 0
MOa-nog1 1000 starmaker 20 100 0 0 0
MO-chd 100 starmaker 20 75 25 0 0
MO-chd/
MOa-nog1
100/500 starmaker 18 16.7 50 33.3 0
MO-chd/
MOa-nog1
100/1000 starmaker 30 20 23.3 46.7 10
MOa-nog1 500 im:7144261 17 100 0 0 0
MOa-nog1 1000 im:7144261 21 100 0 0 0
MO-chd 100 im:7144261 139 71.9 28.1 0 0
MO-chd/
MOa-nog1
100/500 im:7144261 25 4.0 16.0 20.0 60.0
MO-chd/
MOa-nog1
100/1000 im:7144261 22 9.1 9.1 22.7 59.1
Percentage of embryos (n=number of embryos) of the different classes defined
in Fig. 4 based on the expression of tissue-specific markers at 30 hpf (sox19 for
central nervous system, starmaker for otic vesicle and im:7144261 for
notochord) in function of the concentration (in μM) of the nog1 or chd
morpholino-injected.
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genome in a few cells of the dorsal marginal region of the
blastoderm (Fürthauer et al., 1999, Fig. 1I). The onset of nog1
expression was confirmed by RT-PCR. Nog1 is not expressed
maternally, and its zygotic expression starts at the sphere stage
(not shown).
Inactivation of noggin1
Both overexpression studies and nog1 expression pattern
suggest that this gene may be involved in the early patterning of
the D/V axis. To gain further insights in Nog1 function, we
performed knock-down studies by injecting two different
morpholinos directed against nog1 (MOa-nog1 and MOb-
nog1) into 1-cell stage embryos (see Materials and methods).
Surprisingly, whatever morpholino used, no D/V patterning
defects were ever observed and at 24 hpf the embryos appear
strikingly similar to wild-type (compare Figs. 2B to A). Themild
morphological abnormalities observed either after injection of
MOa-nog1 (500–1000 μM) or MOb-nog1 (750–1500 μM)
consisted in a protruding telencephalon, a thinner midbrain–
hindbrain boundary and a slender yolk sac extension (Figs. 2B
and D, 80%, n=220 for 750 μM MOa-nog1) with lower
frequency of phenotypes for MOb-nog1 (30%, n=190 for
750 μM MOb-nog1). Analysis by whole-mount in situ
hybridization using a specific marker of telencephalon (emx1)
either at somitogenesis stages or at 24 hpf failed to reveal any
telencephalon abnormalities (not shown). Concomitant injection
of MOa-nog1 and MOb-nog1 (800–800 μM) did not enhance
the observed phenotype (79%, n=122), suggesting that the
described defects were already maximum after single injection
of MOa-nog1 injection. After 4 days of development, embryos
subjected to morpholinos directed against nog1 lacked all
posterior branchial arches, up to the level of the anteriorly
located Meckel cartilage, which appeared reduced in size but
remained well shaped (not shown).
Double inactivation of chordin and noggin1
Altogether, even though inactivation of nog1 leads to minor
defects at 24 hpf and to rather late branchial arches abnormal-
ities, these results show that nog1 is not essential by itself for the
early establishment of the D/V patterning. However, at gastrula
stage, chd is expressed in a broad dorsal domain that encom-
passes the nog1 expression territory (Figs. 1H, I), suggesting
that Chd may compensate for Nog1 loss of function. To test this
hypothesis, we performed concomitant inactivation of nog1 and
chd. Co-injection of MOa-nog1 (from 500 μM to 1000 μM)
together with MO-chd (100 μM) leads to strengthen the
ventralization phenotype of chd morphant embryos (Fig. 3 and
Table 1). Nearly half of the population of injected embryos
showed a complete deletion of anterior head and a much more
extended hematopoietic territory (Fig. 3C—Table 1) compared
to Chd loss of function (Fig. 3A—Table 1). This phenotype was
obtained as well when injecting MOa-nog1 (750 or 1000 μM)
into a din/din background (compare Fig. 3C with D).
Furthermore, up to 18% of the embryos belonged to anadditional phenotypic class (C3) corresponding to a more
dramatic ventralization, with a complete lack of head structures.
These embryos were essentially made of ventral tissues such as
epidermis and blood (Fig. 3E—Table 1). Among these C3
embryos, a few individuals (3/77 embryos for MO-chd/Moa-
nog1 100/1000 μM) displayed an extreme phenotype with con-
striction of the yolk tube and their blood territory located very
posteriorly (Fig. 3F). Comparable classes were obtained using
co-injection of MOb-nog1 together with MO-chd (Table 1).
Altogether, these results reveal an amplification of the chd
phenotype by co-injection of MO-nog1, suggesting a redundant
function of Nog1 and Chd on the D/V patterning.
Because a second ventralizedmutant ogo has been identified in
the zebrafish, we tested whether inactivation of nog1 may also
amplify the ogo phenotype. Injection of 500 μMMO-ogo resulted
in embryos identical to ogo/ogo mutants (Fig. 1B, 100% n=72).
Co-injection of 800 μM MOa-nog1 enhanced this ventralization
phenotype as half of the population displayed an enlarged ventral
hematopoietic territory similar to chd loss of function (58%,
n=156). On the other hand, the size of the head was not affected
and appeared similar to ogo/ogo mutant (Fig. 1B).
To better characterize the amplification of the chd morphant
phenotype by simultaneous loss of function of Nog1, we
analyzed the expression of various molecular markers specific of
ectodermal or mesodermal tissues at 30 hpf. We first analyzed
the expression territory of a pan neural marker sox19 (Thisse et
al., 2001; Agathon et al., 2003). Four classes were defined
(ranging from wild-type to class III—CIII) in which the neural
519S. Dal-Pra et al. / Developmental Biology 298 (2006) 514–526plate progressively became thinner and shorter (Figs. 4A–H).
While CI class is observed for single inactivation of chd, the CII
and CIII classes were only observed after double inactivation of
chd and nog1 (Table 2). In extreme cases (CIII), only dis-
continuous stretches of neural tube remained (Figs. 4D, H). The
second marker used was starmaker (Thisse et al., 2001; Söllner
et al., 2003) specific of the otic vesicle. Four classes were also
defined (Figs. 4I–L), CI showing small otic vesicle (Fig. 4J), CII
consisting of smaller, round otic vesicles (Fig. 4K) and CIII
showing a unique, small round otic vesicle located at the midline
(Fig 4L). For this last class, the otic vesicle appeared located at
the anterior extremity of the remaining neural tube. As for the
analysis with sox19, CII and CIII phenotypes were only found
for the double chd/nog1 inactivation (Table 2).We then analyzed
the effect of chd and nog1 loss of function on axial mesoderm
using a specific notochordal marker im:7144261 (Thisse andFig. 5. Analysis of double chordin–noggin1 morphants for the expression of early m
ventral part of the gastrula, cyp26a (D–F) expressed at the margin and in anterior neu
G) Wild type (WT), (B, E, H) injection of 100 μM of MO-chd (class I, CI), (C, F, I) inj
indicate the dorsal limits of ved expression. Arrowheads in panels D–F indicate the a
dorsal limits of the presumptive epidermis labeled with foxi1. Embryos are in animal
animal pole up in panels D–E and G–I lower panels.Thisse, 2004). Again, four classes from wild-type to CIII were
also defined, CI embryos showing a normal morphology
anteriorly but a wavy notochord in the tail region (Fig. 4N).
CII embryos were characterized by a shorter axis, with a wild-
type notochord interrupted at the level of the anus (Fig. 4O).
Finally, CIII embryos displayed a very short notochord, which
failed to elongate posterior to the anus (Fig. 4P). As mentioned
for sox19 and starmaker, CII and CIII did not exist for single
inactivation of chd (Table 2).
In summary, this analysis revealed much stronger pheno-
types when inhibiting nog1 and chd together than for single
inactivation of chd or nog1.
We then studied the effect of inactivation of chd and nog1 at
early developmental stages using various gastrula and early
somitogenesis markers specific of ectodermal and mesendoder-
mal territories (Figs. 5, 6 and Table 3). We first analyzed theolecular markers. Expression of ved (A–C), a Bmp target gene expressed in the
ral plate, foxi1 (G–I), a marker of presumptive epidermis at gastrula stage. (A, D,
ection of 100–800 μM chd-nog1MOs (class II, CII). Arrowheads in panels A–C
nterior limit of the neural plate labeled with cyp26a and arrowheads in G–I, the
pole view dorsal to the right in panels A–C and G–I upper panels. Dorsal views
Fig. 6. Analysis of double chordin–noggin1 morphants with endomesodermal markers. (A–C) Expression of draculin (drl) specific of presumptive hematopoietic
territory at 70% epiboly. (D–F) Expression of the paraxial marker myf5 at the 3-somite stage. (G–I) Expression of the cephalic mesendodermal marker follistatin1
(fst1) at 80% epiboly. (J–L) Expression of the prechordal plate marker hgg1 which labels the presumptive hatching gland at 75% epiboly. (M–O) Expression of the
notochordal marker floating-head (flh) at 75% epiboly. (A, D, G, J, M) Wild-type embryos (B, E, H, K, N), 100 μM MO-chd-injected embryos (C, F, I, L, O)
100–800 μM chd-nog1 MOs-injected embryos. (A–C) Vegetal pole views, dorsal to the right. (D–F) Dorsal views anterior to the left. (G–O) Dorsal views, animal
pole up.
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(Gilardelli et al., 2004). Inwild-type, expression of ved is detected
in the ventral part of the gastrula and is excluded from the dorsal
side of the embryo at 50% epiboly (Thisse et al., 2001, Fig. 5A).
In embryos injected with 100 μM of MO-chd, expression of ved
was expanded towards dorsal (Fig. 5B). In embryos injected with
both morpholinos against chd and nog1 (100 μM, 800 μM), this
enlargement was even more pronounced, showing a strong
ventral expansion of ved (Fig. 5C). Under the same experimental
conditions, the anterior neurectodermal territory labeled withcyp26a (Thisse et al., 2001; Fürthauer et al., 2004) appeared
strongly reduced in embryos injected with MO-chd (Fig. 5E) and
disappeared almost completely in doublemorphants (Fig. 5F). On
the other hand, foxi1, specific of presumptive epidermis (Thisse et
al., 2001; Fürthauer et al., 2004), was expanded on the dorsal side
of the embryo, with a much stronger expansion in the case of
double inactivation of chd and nog1 (Figs. 5G–I).
During gastrulation, expression of draculin (drl), a marker
specific of presumptive ventral hematopoietic mesoderm
(Herbomel et al., 1999; Thisse et al., 2001), extended toward
Table 3
Frequency of phenotypic classes obtained for single and double chd-nog1





Probe n Phenotype (%)
wt CI CII
MOa-nog1 800 ved 68 100 0 0
MO-chd 100 ved 48 25 50 25
MO-chd/MOa-nog1 100/800 ved 76 14.5 42.1 43.4
MOa-nog1 800 cyp26a 19 100 0 0
MO-chd 100 cyp26a 35 17.1 82.9 0
MO-chd/MOa-nog1 100/800 cyp26a 31 25.8 54.8 19.4
MOa-nog1 800 foxi1 36 100 0 0
MO-chd 100 foxi1 37 5.4 94.6 0
MO-chd/MOa-nog1 100/800 foxi1 40 25.0 47.5 27.5
MOa-nog1 800 drl 32 100 0 0
MO-chd 100 drl 60 0 85 15
MO-chd/MOa-nog1 100/800 drl 77 7.8 27.3 64.9
MOa-nog1 800 myf5 58 100 0 0
MO-chd 100 myf5 62 8.1 88.7 3.2
MO-chd/MOa-nog1 100/800 myf5 59 6.8 52.5 40.7
MOa-nog1 800 fst1 49 100 0 0
MO-chd 100 fst1 51 7.8 47.1 45.1
MO-chd/MOa-nog1 100/800 fst1 30 3.3 26.7 70
MOa-nog1 800 hgg1 50 60 32 8
MO-chd 100 hgg1 48 25 66.7 8.3
MO-chd/MOa-nog1 100/800 hgg1 57 28.1 45.6 26.3
MOa-nog1 800 flh 84 100 0 0
MO-chd 100 flh 116 11.5 70.1 18.4
MO-chd/MOa-nog1 100/800 flh 199 7.5 40.8 51.7
Percentage of embryos (n=number of embryos) of the different classes defined in
Figs. 5 and 6 on the expression of tissue-specific markers at early developmental
stages (ved for the ventral part of the gastrula, cyp26a for the margin and the
anterior part of neural plate, foxi1 for the presumptive epidermis, drl for the
hematopoietic mesoderm, myf5 for the paraxial mesoderm, fst1 for the cephalic
mesendoderm, hgg1 for the prechordal plate and flh for the notochord) in
function of the concentration (in μM) of MOa-nog1 and/or MO-chd-injected.
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This enlargement of ventral mesoderm was even more
pronounced in chd/nog1 morphants (Fig. 6C). At early somito-
genesis stages, myf5, a muscle-specific marker labeling the
segmental plate (Thisse et al., 2001) appeared strongly reduced
after injection of MO-chd (Fig. 6E) remaining only detectable in
adaxial cells and in adjacent paraxial mesoderm. In embryos
injected with MO-chd andMOa-nog1,myf5 labeling was almost
absent and remained only in a few adaxial cells (Fig. 6F).
Similarly, cephalic mesendoderm, observed using follistatin1
(fst1—Bauer et al., 1998; Thisse et al., 2001), was reduced along
the D/V axis and almost absent after double inactivation of chd
and nog1 (Figs. 6G–I). In the axis, at gastrulation, analysis of
hgg1 (Thisse et al., 1994) revealed that the prechordal plate
was reduced after inactivation of chd and almost absent in
double morphants (Figs. 6J–L). Finally, expression of floating
head (flh—Talbot et al., 1995) specific of chorda mesoderm
appeared thinner in chdmorphant and was further reduced along
the antero-posterior axis in embryos injected with both MO-chd
and MOa-nog1 (Figs. 6M–O).
Altogether, this analysis using specific molecular markers
shows that, already at early developmental stages, the double
inactivation of chd and nog1 strongly enhances the ventraliza-
tion phenotype observed after Chd loss of function.Rescue of chd-nog1 morphants phenotype by addition of fgf8
or follistatin1 RNA
Because Chd and Nog1 negatively interact with Bmps by
direct binding, the aggravation of the ventralization phenotype
resulting from the inactivation of nog1 in chd loss of function
context strongly suggests that Nog1 is responsible for the Bmp
antagonistic activity remaining in the chd mutant. To demon-
strate that the effect of Nog1 is due to its Bmp inhibitory
properties, we investigated whether we could rescue the ventra-
lization phenotypes obtained for chd-nog1 morphants by other
factors inhibiting Bmp activity. To perform such rescue experi-
ments, we chose fgf8, which controls the expression of the bmp
genes via the stimulation of the FGF receptor 1 and the activation
of the Ras/MAP kinase signaling pathway (Fürthauer et al.,
2004). In addition, we used another factor, follistatin1 (fst1),
known to be able to antagonize Bmp activity and for which its
misexpression leads to dorsalization phenotypes (Hemmati-
Brivanlou et al., 1994; Bauer et al., 1998, our own results).
All embryos injected with MO-chd or MO-chd plus MOa-
nog1 showed ventralization (Fig. 7). On the other hand, co-
injections of high dose of fgf8 or fst1 RNA (15 pg and 400 pg
respectively) in chd or chd-nog1morphants reverted this pheno-
type to dorsalization, identical to the dorsalization phenotype
observed after single injection of fgf8 or fst1 RNA (not shown).
After co-injection of lower doses of fgf8 or fst1 RNA (5 pg and
50 pg respectively), a small proportion of embryos (between 3%
n=62 and 31% n=93) were ventralized while the others
presented a wild-type-like or a dorsalized morphology (Fig. 7).
In this set of experiments, the percentage of dorsalized
embryos was much higher for the rescue of chd (73% n=62 for
fgf8 and 57% n=86 for fst1) than for the rescue of chd-nog1
morphants (49% n=87 for fgf8 and 30% n=93 for fst1). Due to
the additional lack of nog1, injection of the same amounts of
FGF8 or Fst1 led to a weaker dorsalization in chd-nog1
morphants than in chd morphants.
Additional analysis performed by in situ hybridization
looking at the expression of foxi1, ved and cyp26a confirmed
that the rescue of chd-nog1morphants phenotype by addition of
fgf8 or fst1 RNA is already effective at gastrula stage (not
shown).
Follistatin-like 2 (Fstl2): another player involved in the control
of Bmp activity
Our previous experiments demonstrate that Nog1 carries an
anti-bmp activity still present in the chd mutant and explains,
at least in part, the remaining dorsal tissues observed in din/
din mutant. Nevertheless, after double inactivation of chd
and nog1, the ventralization phenotype is less severe than the
one observed after injection of high dose of bmp RNA (Fig.
1F). This suggests that other factors sharing an anti-Bmp
activity may be present in the early embryo to establish the D/
V axis.
InXenopus, Follistatin has been suggested to play such a role,
but in zebrafish, follistatin1 (fst1) transcripts are first detected at
70% epiboly in cephalic mesendoderm (Bauer et al., 1998;
Fig. 7. Fgf8 and Fst1 overexpression rescues chordin and chordin–noggin1 morphants. (A) Example of a ventralization phenotype observed after injection of chd or
chd-nog1 morpholinos. (B) Example of wild-type like morphology obtained after injection of fgf8 or fst1 RNA into chd or chd-nog1 morphants (C). Example of a
dorsalization phenotype observed after injection of fgf8 or fst1 RNA into chd or chd-nog1 morphants. Embryos are observed at 30 hpf in lateral view, anterior to the
left. Lower panel: the horizontal bars represent the percentage of embryos displaying a ventralized phenotype (yellow), a wild-type like morphology (green) or a
dorsalized phenotype (blue) in chd morphants (MO-chd, 100 μM), double chd-nog1 morphants (MO-chd/MO-nog1—100 μM/800 μM), in chd or chd-nog1
morphants injected with 5 pg of fgf8 RNA (MO-chd+RNA fgf8; MO-chd/MO-nog1+RNA fgf8, respectively) or with 50 pg of fst1 RNA (MO-chd+RNA fst1; MO-
chd/MO-nog1+RNA fst1, respectively). Due to the lack of two Bmp inhibitors, the rescue of ventralization phenotype (wild-type-like and dorsalized phenotypes) by
fgf8 and fst1 is less efficient in double chd-nog1 morphants than in single chd morphants. n: number of embryos analyzed.
522 S. Dal-Pra et al. / Developmental Biology 298 (2006) 514–526Thisse et al., 2001), too late for assuming that Fst1 controls the
D/V axis formation. In agreement with this hypothesis, inacti-
vation of fst1 by morpholino injection results in a late phenotype
characterized by the lack of posterior branchial arches while the
D/V patterning remains unaffected (not shown). In addition,
injection of MO-fst1 failed to amplify the ventralization pheno-
type of chd morphant (not shown).
In a search for potential candidates that may control the
establishment of the D/V axis, we identified a second follistatin
gene, follistatin2 (fst2, Fig. S1). As for fst1, overexpression of
fst2 by sense RNA injection causes dorsalization (not shown).
Analysis of fst2 expression shows that it begins at the 14-somiteFig. 8. Follistatin-like 2 (Fstl2) is involved in the control of the D/V axis formation.
embryonic shield (sh). (B) At 60% epiboly, fstl2 transcripts are observed in notochord
is restricted to the notochord. (E) Morphological analysis of morphant phenotypes at
display D/V axis similar to wild-type (WT like). Chd morphants or mutants displ
hematopoietic territory (C1). Double chd-fstl2; chd-nog1 or triple chd-fstl2-nog1mor
enlargement of ventro-posterior territories (C2) or an extreme ventralization phen
percentage of embryos observed for the corresponding class observed for the diffe
Analysis of single, double and triple morphants with ved, a marker of ventral territorie
at 50% epiboly, in wild-type, ved is detected in the ventral part of the gastrula, in CI
more pronounced. (G) Analysis by in situ hybridization of single, double and triple m
stage. Embryos are in lateral view, animal pole up. Compared to wild-type-like em
strongly reduced while it is almost absent in CII. (I) For the different combinations o
for the classes described in panels F and G and analyzed by in situ hybridization wstage in the proximal region of ventral and dorsal parts of the
somites. This myotomal expression is maintained until the end
of tail elongation. Later on, fst2 transcripts are detected in
anterior branchial arches (Fig. S2).
Therefore, while these proteins carry an anti-Bmp activity
(Bauer et al., 1998; our unpublished observations), the expres-
sion pattern of the two zebrafish follistatin genes fst1 (Bauer et
al., 1998; Thisse et al., 2001) and fst2 (Fig. S2) is not supportive
of their implication during early axis formation.
However, a growing number of proteins have been described
to share sequence similarities to Follistatin, defining thereby the
Follistatin-domain family (Phillips and de Kretser, 1998). The(A) Expression of fstl2 starts at the onset of gastrulation in the deep cells of the
(n) as well as in the yolk syncytial layer (ysl). (C–D) At 75% epiboly, expression
30 hpf. Single fstl2 or nog1 morphants as well as double fstl2–nog1 morphants
ay a ventralization phenotype characterized by a small head and an enlarged
phants display stronger ventralization phenotype with very small head and strong
otype with lack of head (C3). Graphs underneath each picture represent the
rent combination of morpholino injected described in the table in panel H. (F)
s at gastrula stage. Embryos are in vegetal pole view, dorsal to the right. Whereas
, expression of ved is expanded towards dorsal. In CII, this enlargement is even
orphants using cyp26a, a marker of margin and of anterior neural plate at gastrula
bryos, in CI, the anterior neurectodermal territory labeled with cyp26a appears
f morpholinos used, the table records the number and the percentage of embryos
ith ved and cyp26a.
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of nearly 70 amino acids containing 10 cysteine residues at
strongly conserved positions (Patthy and Nikolics, 1993). All
Follistatin family proteins appear to be secreted, being either
released in the extracellular space or acting as transmembrane
proteins. Based on the activin-binding activity of Follistatin,
follistatin modules have been proposed to mediate growth
factors binding (Patthy and Nikolics, 1993). In addition, several
studies suggest that at least one other Follistatin-module
containing factor, namely Follistatin-like protein (Fstl, also
named Follistatin-related protein, Frp) is implicated in the
regulation of TGFβ signaling. Fstl was originally isolated as a
TGFβ1 inducible gene, in accordancewith its potential feedback
inhibitor function (Shibanuma et al., 1993). Fstl is expressed in
the organizing center and chordamesoderm of the mouse, chick
and Xenopus embryos, suggesting its implication in the early
axis formation of several vertebrate species (Patel et al., 1996;
Okabayashi et al., 1999; De Groot et al., 2000). While
overexpression of fstl in Xenopus embryos appears to have no
effect on development (Okabayashi et al., 1999), the inhibition
of fstl function through antisense oligonucleotides in the chick
results in axial defects (Towers et al., 1999).
In zebrafish, we isolated two follistatin-like (fstl) genes,
fstl1 and fstl2, which can be aligned along their whole peptide
sequence with their Xenopus, chicken and mouse counterparts
(Fig. S3). Phylogenetic analysis confirmed that both fish
genes belong to the Fstl branch of the Follistatin-domain
family (Fig. S3B).
Fstl2 becomes first detectable at the onset of gastrulation
(Fig. 8A and Fig. S4). Transcripts localize to the deep layer of the
embryonic shield, a territory also expressing nog1. Weak fstl2
expression is also detected in the extraembryonic yolk syncytial
layer (Fig. 8B). The expression of fstl2 in the axial mesendoderm
is maintained throughout gastrulation (Figs. 8C, D). In contrast,
expression of fstl1 is not detectable at gastrula stage and first
transcripts appear at early somitogenesis in adaxial cells (Fig.
S5). Therefore, the expression of fstl2 at early developmental
stages suggests a possible involvement of this gene in axis
formation while fstl1 is expressed too late to favor a possible
function of this gene in this process.
In agreement with previous report in Xenopus (Okabayashi et
al., 1999), we found that overexpression of Fstl2 by injection of
sense RNA (from 10 pg up to 600 pg, n>100 for each condition)
at the 1-cell stage failed to affect the embryonic development. As
well, inactivation of fstl2 through antisensemorpholino injection
did not affect the D/V patterning. Embryos were analyzed based
on their morphology at 30 hpf or for the expression of specific
molecular markers at gastrula stage, cyp26a for the dorsal
neurectoderm as well as ved for the ventral territories. For all
concentrations used (up to 1000 μM), injected embryos
appeared normal for the formation of the D/V axis and 100%
embryos displayed wild-type like morphology and wild-type
expression of the molecular markers used. Double inactivation
of nog1 (MOa-nog1 500 μM) and fstl2 (MO-fstl2 1000 μM)
also failed to affect this process. Nevertheless, similarly to the
enhancement of chd phenotype by additional inactivation of
nog1, inactivation of fstl2 strongly enhanced the ventralizationphenotypes observed in chdmorphants. Finally, the triple inacti-
vation of Chd, Nog1 and Fstl2 did not result in new phenotypes.
Nevertheless, the percentage of strongly ventralized embryos
was increased, reflecting a much higher penetrance of this phe-
notype (Fig. 8). Altogether, our data demonstrate that, in
addition to Chd, two other factors, Nog1 and Fstl2, are required
at blastula and early gastrula stages to inhibit Bmp activity on the
dorsal side of the zebrafish embryo.
Discussion
The genetic dissection of the D/V patterning of the zebrafish
embryo identified several dorsalized mutations (Mullins et al.,
1996) includingmutations affecting themorphogenes of the D/V
axis, namely bmp2b (swirl) (Kishimoto et al., 1997) and bmp7
(snailhouse) (Dick et al., 2000; Schmid et al., 2000) as well as
two ventralized mutants called dino (Hammerschmidt et al.,
1996) and ogon corresponding respectively to inactivation of
chordin or sizzled (Schulte-Merker et al., 1997; Yabe et al.,
2003; Martyn and Schulte-Merker, 2003). Loss of function of
these two Bmp antagonists results in expanding the ventral
territories (epidermis and ventral hematopoietic mesoderm)
associated with corresponding reduction of the dorsal ones, brain
and dorsal mesoderm. Nevertheless, embryos lacking either the
chd or ogo genes or both still display substantial amount of
dorsal and dorso-lateral structures (neural tube, paraxial
mesoderm) compared to completely ventralized embryos re-
sulting from overexpression of Bmp (Figs. 1E, F). This strongly
suggests that other Bmp antagonists may be responsible for the
formation of the dorsal tissues remaining in chd/ogo double
mutants.
Various candidates for carrying such a function have been
reported in other species. In particular, Noggin (Zimmerman et
al., 1996) and Follistatin (Fainsod et al., 1997) were shown to be
able to antagonize Bmp activity in vivo. In zebrafish as well,
overexpression of Noggin or Follistatin results in strong dorsal-
ization phenotypes (Bauer et al., 1998; Fürthauer et al., 1999).
Likely due to the teleosts whole genome duplication, several
noggin and follistatin genes are present in the zebrafish. Three
noggin genes were identified (Fürthauer et al., 1999) but only
one, nog1, is expressed early enough and at the right place to
play a role in the establishment of the D/V patterning. However,
we show here that its single inactivation, while strongly affecting
formation of the branchial arches at late stages, has no effect on
early embryonic development. Because nog1 expression is
included within the chd expression domain, we studied the effect
of the double inactivation of chd plus nog1. Inactivation by
morpholino knock-down of nog1 in either chd morphants or in
homozygous din/din mutants strongly amplifies the chd ventra-
lization phenotype. This clearly demonstrates that nog1 acts
redundantly to chd and is responsible, at least in part for the
remaining dorsal and dorso-lateral tissues observed in chd
mutants. As well, nog1 loss of function is able to amplify the
ventralization phenotype of the second ventralized mutant, ogo.
The gene inactivated in this mutant sizzled has recently been
shown to bind and inhibit Tolloid (Lee et al., 2006; Muraoka et
al., 2006). Therefore, inactivation of sizzled in an ogo mutant
525S. Dal-Pra et al. / Developmental Biology 298 (2006) 514–526results in an upregulation of Tolloid and in a downregulation of
Chordin. In consequence, the ogo mutant phenotype can be
considered as a weak mutant of chordin, which can be enhanced
by simultaneous loss of nog1.
We further analyzed the implication of other factors in the D/
V patterning, namely the follistatin genes. To do so, we cloned
two follistatin genes and found that fst2 is expressed during late
development in a subset of branchial arches. Because of its late
expression, this gene is likely not to be involved in early
patterning, even though when overexpressed, this results in a
dorsalization phenotype showing its ability to antagonize the
Bmp activity. Similarly, fst1, which starts to be expressed by
70% epiboly in cephalic mesendoderm, is able to antagonize
Bmp activity in gain of function experiments. However, fst1 is
expressed too late to play a major role in D/V axis formation.
Indeed, inactivation of fst1 results solely in deletion of posterior
branchial arches and failed to amplify the ventralization pheno-
type of chd morphants.
In Xenopus, recent studies revealed that the depletion of chd,
nog and fst results in a catastrophic loss of dorsal development,
with excessive amounts of ventral tissues at the expense of
dorsal structures (Khokha et al., 2005). Inactivation of two of
these Bmp antagonists has only a weak effect. Similarly in the
mouse, double inactivation of chd and nog affects only the
development of prosencephalon (Bachiller et al., 2000). In
contrast, we show here, in the zebrafish, that double inactivation
of chd and nog1 results in embryos displaying a much stronger
ventralization phenotype. Nevertheless, the triple inactivation of
chd, nog and fst in Xenopus has a more dramatic effect than
double chd, nog inactivation in the fish, suggesting that other
Bmp antagonists may exist. We show here that Follistatin itself
does not carry this function.
In a search for other potential candidates to carry this
function, we identified two follistatin-like genes. While fstl1 is
expressed too late to assume such a role, fstl2 is expressed early
on and in the fish organizer. As described in Xenopus, we found
that overexpression of follistatin-like factors has no effect on
zebrafish development. Nevertheless, inactivation of fstl2 by
morpholino knock-down strongly enhances the chd ventraliza-
tion phenotype in a way similar to what we observed for nog1.
In addition, triple inactivation of chd, nog1 and fstl2 increases
the frequency of strong ventralized phenotype. Therefore, it
appears that the function performed by Fst in Xenopus is likely
to be carried by Fstl2 in zebrafish. However, while Fstl2 is
involved in establishment of D/V patterning, it likely requires a
still unknown cofactor to bind and inhibit BMP activity.
In conclusion, we show here that Chd appears to be the main
Bmp antagonist sufficient to maintain a proper gradient of Bmp
activity. In zebrafish, most of the remaining dorsal and dorso-
lateral territories, in both the mesodermal and ectodermal layers,
still present in chd mutants result from the anti-Bmp activity
carried by Nog1 and Fstl2 at blastula and gastrula stages.
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